164 related articles for article (PubMed ID: 1327922)
1. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
Murray KJ; England PJ
Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
[No Abstract] [Full Text] [Related]
2. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
Nicholson CD; Shahid M
Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
[No Abstract] [Full Text] [Related]
3. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
Némoz G; Prigent AF; Picq M; Pacheco H
Biochem Pharmacol; 1982 Nov; 31(21):3353-8. PubMed ID: 6293510
[No Abstract] [Full Text] [Related]
4. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
6. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
[No Abstract] [Full Text] [Related]
7. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Worby A; Mensah LM; Murray KJ
Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
[No Abstract] [Full Text] [Related]
8. Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.
Raeburn D; Souness JE; Tomkinson A; Karlsson JA
Prog Drug Res; 1993; 40():9-32. PubMed ID: 8395068
[No Abstract] [Full Text] [Related]
9. The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity.
Elliott KR; Berry JL; Bate AJ; Foster RW; Small RC
J Enzyme Inhib; 1991; 4(3):245-51. PubMed ID: 1645399
[TBL] [Abstract][Full Text] [Related]
10. Methylxanthine inhibitors of phosphodiesterases.
Wells JN; Miller JR
Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
[No Abstract] [Full Text] [Related]
11. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
Wells JN; Kramer GL
Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
[No Abstract] [Full Text] [Related]
12. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
Zhu WH; Majluf-Cruz A; Omburo GA
Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
[TBL] [Abstract][Full Text] [Related]
14. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
Levin RM; Weiss B
Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
[No Abstract] [Full Text] [Related]
15. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
Raeburn D; Karlsson JA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
[No Abstract] [Full Text] [Related]
17. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
Chasin M; Scott C
Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
[No Abstract] [Full Text] [Related]
18. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
19. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
Davis CW
Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
[TBL] [Abstract][Full Text] [Related]
20. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
